Audentes enrols first patient in INCEPTUS study for X-Linked Myotubular Myopathy

Audentes Therapeutics has reported that the first patient has been enrolled in INCEPTUS, a study to characterise the disease presentation in children suffering with X-Linked Myotubular Myopathy (XLMTM).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news